Skip to main content

Oncology Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • News
  • Events coverage
  • Features
    • Opinion
    • Journal articles
    • Events calendar
    • Spotlights
    • In Focus

    Follow us on social media

  • Our Journals
  • Topic
    • Prevention, detection and screening
      • Biomarkers
      • Diagnostics
      • Epidemiology
      • Genetics & genomics
      • Prevention & screening
    • Bench to bedside
      • Cancer biology
      • Clinical trials
      • Drug approvals
      • Drug development
      • Emerging technologies
      • Industry & business
      • Preclinical research
    • Treatments
      • Chemotherapy
      • Immuno-oncology
      • Personalized & precision medicine
      • Radiology
      • Surgery
      • Targeted therapies
    • Supportive oncology
      • Palliative care
      • Patient perspectives
      • Quality of life
      • Survivorship
      • Virtual healthcare

    Follow us on social media

  • Disease specialty
    • Breast
    • Colorectal
    • Endocrine
    • Gastrointestinal
    • Genitourinary
    • Gynecologic
    • Head & neck
    • Hematologic
    • Hepatic
    • Lung
    • Neurologic
    • Pancreatic
    • Prostate
    • Rare tumors
    • Renal
    • Skin

    Follow us on social media

  • Multimedia
    • Videos
    • Podcasts
    • Infographics
    • Webinars
    • Downloadable eBooks

    Follow us on social media

  • Register
[COFFEE CHAT] The emotional and psychological impact of hepatocellular carcinoma on patients, families and caregivers WATCH NOW

Renal

Renal cancer – also termed kidney cancer – is a disease in which kidney cells become cancerous; renal cell carcinoma is the most common type of adult kidney cancer, accounting for approximately 90% of kidney cancers.

View more

There are several other types of renal cancer, named depending on the cell type that is affected. These are clear cell renal cell carcinoma and non-clear cell renal cell carcinoma (including papillary renal cell carcinoma, chromophobe renal cell carcinoma). Rare forms are collecting duct renal cell carcinoma, multilocular cystic renal cell carcinoma, medullary carcinoma, mucinous tubular and spindle cell carcinoma and neuroblastoma-associated renal cell carcinoma. Other types of kidney cancers include transitional cell carcinomas, Wilms tumors, and renal sarcomas.

Often in terms of symptoms, renal cancer exhibits no obvious signs and a tumor in this region may only be discovered during tests for another condition. Symptoms can include blood in urine, a persistent pain in the lower back or side and a lump or swelling. Causes of kidney cancer include being obese, smoking, hypertension, a family history of the disease and long-term dialysis. Treatment for kidney cancer includes surgery to remove part or all of the affected kidney, cryotherapy or radiotherapy ablation, biological therapies, embolization or radiotherapy.

The articles in this section cover the latest from renal cancer from different perspectives including clinical, research and patient. Oncology Central features the latest breaking news, peer-reviewed research articles, expert opinion pieces and more.
If you want access to all of this and more content, and regular updates to your emails, register with Oncology Central now.

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Expert Panel
  • Journals
  • Permissions and content ownership policy
  • Press release policy
  • Whitelist emails

Contact

Contact Us

Office info

Oncology Central is powered by Taylor & Francis Group

Oncology Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Oncology Central